Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Jan 15, 2021 43.10 +5.12   
 24Storage 24STOR Jan 15, 2021 41.60 +1.46   
 2cureX 2CUREX Jan 15, 2021 18.20 -0.55   
 A3 Allmänna IT- och Telekomaktiebolaget ATRE Jan 15, 2021 18.80 0.00   
 AAC Clyde Space AAC Jan 15, 2021 3.75 0.00   
 AAK AAK Jan 15, 2021 163.70 +0.15   
 ABB ABB Jan 15, 2021 247.20 -2.83   
 Abelco Investment Group ABIG Jan 15, 2021 0.11 0.00   
 ABG Sundal Collier Holding ASCO Jan 15, 2021 5.74 0.00   
 Abliva ABLI Jan 15, 2021 0.77 +1.86   
 Absolent Group ABSO Jan 15, 2021 401.00 +0.25   
 Absolicon ABSL Jan 15, 2021 123.50 -1.98   
 AcadeMedia ACAD Jan 15, 2021 81.50 -1.93   
 Acarix ACARIX Jan 15, 2021 1.35 +0.75   
 Acconeer ACCON Jan 15, 2021 29.50 -3.28   
 Acosense ACOS Jan 15, 2021 1.63 -6.05   
 AcouSort ACOU Jan 15, 2021 26.20 +2.75   
 Acrinova ACRI Jan 15, 2021 19.40 -2.51   
 ACROUD ACROUD Jan 15, 2021 2.86 +0.35   
 Actic Group ATIC Jan 15, 2021 18.30 -1.88   
 Active Biotech ACTI Jan 15, 2021 1.65 -1.67   
 AcuCort ACUC Jan 15, 2021 4.69 -2.29   
 Adapteo ADAPT Jan 15, 2021 96.90 -1.12   
 AdderaCare ADDERA Jan 15, 2021 4.44 +0.91   
 AddLife B ALIFB Jan 15, 2021 151.60 -3.81   
 Addnode Group B ANODB Jan 15, 2021 272.50 -2.33   
 Addtech B ADDTB Jan 15, 2021 117.00 -2.50   
 ADDvise Group A ADDVA Jan 15, 2021 1.90 -4.52   
 ADDvise Group B ADDVB Jan 15, 2021 1.41 +1.44   
 Adevinta ADEO Jan 15, 2021 124.70 -0.72   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK